Seth Lederman is Chief Executive Officer of Tonix Pharmaceuticals Holding Corp.. Currently has a direct ownership of 112,177 shares of TNXP, which is worth approximately $15,704. The most recent transaction as insider was on Mar 25, 2022, when has been sold 100,000 shares (Common Stock, $0.001 par value) at a price of $0.24 per share, resulting in proceeds of $24,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 112K
0% 3M change
0% 12M change
Total Value Held $15,704

SETH LEDERMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2022
BUY
Open market or private purchase
$24,000 $0.24 p/Share
100,000 Added 47.13%
112,177 Common Stock, $0.001 p...
Sep 28 2021
BUY
Open market or private purchase
$7,320 $0.61 p/Share
12,000 Added 49.63%
12,177 Common Stock, $0.001 p...
Dec 30 2020
BUY
Open market or private purchase
$23,800 $0.68 p/Share
35,000 Added 22.84%
118,267 Common Stock, $0.001 p...
SL

Seth Lederman

Chief Executive Officer
Chatham, NJ

Track Institutional and Insider Activities on TNXP

Follow Tonix Pharmaceuticals Holding Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNXP shares.

Notify only if

Insider Trading

Get notified when an Tonix Pharmaceuticals Holding Corp. insider buys or sells TNXP shares.

Notify only if

News

Receive news related to Tonix Pharmaceuticals Holding Corp.

Track Activities on TNXP